Page 59 - Read Online
P. 59

Al-Sammarraie et al. Neuroimmunol Neuroinflammation 2021;8:53-63  I  http://dx.doi.org/10.20517/2347-8659.2020.34          Page 55

               Table 1. Expression of BMP signaling components before and after SCI in rodent models
                BMP signaling   SCI
                component     model                             Outcomes                              Ref.
                BMP ligands    Rats   BMP7 mRNA was mildly expressed in glial cells in intact spinal cord but markedly expressed in   [27]
                                    glial cells and motoneurons post-SCI
                               Rats  BMP2/4 mRNA was mildly expressed in intact spinal cord but markedly expressed in   [23]
                                    oligodendrocytes, astrocytes, and microglia surrounding the damaged site post-SCI
                               Mice  BMP2, 4, and 7 levels were increased in neurons, microglia, oligodendrocytes, and NSCs post-  [37]
                                    SCI, which enhanced astrocyte proliferation. BMP4 promoted differentiation of astrocytes and
                                    inhibited differentiation of neurons and oligodendrocytes
                               Rats  BMP2 and 4 levels were increased post-SCI and promoted differentiation of the engrafted OPCs   [40]
                                    cells into astrocytes
                               Mice  BMP7 expression was increased after SCI and further augmented after agmatine treatment,   [30]
                                    leading to reduced collagen scar formation and improved BBB score post-SCI
                               Rats  BMP4 expression was increased in astrocytes cultured from injured thoracic spinal cord   [36]
                               Rats  BMP2/4 expression was increased after SCI and associated with low BBB scores  [29]
                               Rats  BMP7 was expressed in glial cells of the intact spinal cord and increased in glial cells and   [27]
                                    motoneurons after SCI
                               Mice  BMP2 was slightly expressed in intact spinal cord and markedly increased post-SCI  [38]
                               Mice  BMP4 level was increased in neurons of gray and white matter and ependyma cells near the   [28]
                                    damaged site post-SCI
                               Rats  BMP4 was overexpressed after acute SCI                           [57]
                               Rats  BMP2, 3, 4, 5, 7, 9, 12, and 13 were expressed in intact spinal cord  [16]
                BMP receptors  Rats  BMPR1A and BMPR2 expression levels were increased in neurons post-SCI  [23]
                BMP antagonists  Rats  Noggin was minimally expressed in intact spinal cord           [16]
                Canonical pathway  Mice  p-Smad1, 5, and 8 were activated in neurons, oligodendrocytes, OPCs, astrocytes, and NSCs post-  [37]
                                    SCI
               BMP: bone morphogenic protein; SCI: spinal cord injury; OPCs: oligodendrocyte precursor cells; NSCs: neural stem cells; BBB: Basso,
               Beattie, and Bresnahan; BMPR: BMP receptor


               Table 2. Effects of BMP treatment on neuronal and non-neuronal cells in SCI in in vitro models
               BMP signaling   Treatment                         Outcomes                             Ref.
               component
               BMP ligands   BMP7     BMP7 inhibited tumor necrosis factor α-mediated oligodendrocyte death  [56]
                             BMP7     BMP7 inhibited glutamate induced neuronal cell death            [24]
                             BMP4    In vitro culture of NSCs in the presence of BMP4 resulted in amelioration of oligodendrocyte   [25]
                                      differentiation and increase in astrocyte differentiation. Smad1 and 5 were activated in
                                      response to BMP4 treatment of NSCs
                             BMP7     Noggin expressing OPCs treated with BMP7 showed less astrocytic differentiation  [16]
               BMP antagonists  Noggin  Noggin treatment reduced astrocyte numbers. Inhibition of BMP4 using noggin attenuated   [37]
                                      differentiation of NSCs into astrocytes
                             Noggin   Noggin treatment of OPCs partially reduced astrocytic differentiation  [40]
                             Noggin   Noggin treatment reduced differentiation of OPCs into astrocytes in astrocyte conditioning   [36]
                                      media. p-Smad1, 5, and 8 levels were increased in OPCs in astrocyte conditioning media
                                      compared to control. OPCs cultured in astrocyte conditioning media predominantly
                                      differentiated into astrocytes
                             Noggin and  Treatment attenuated BMP4 induced activation of caspase-3 for cell death in neurons and   [57]
                             LDN193189 oligodendrocytes post-SCI
                             Noggin   Noggin treatment reduced astrocytic differentiation and increased the differentiation of NSCs   [25]
                                      into oligodendrocytes
               BMP: bone morphogenic protein; SCI: spinal cord injury; OPCs: oligodendrocyte precursor cells; NSCs: neural stem cells


               Furthermore, in vitro studies [24,25]  extensively elucidated the protective and deregulatory role of BMP
               components in a variety of cellular events on both neuronal and non-neuronal cells, which are summarized
               in Table 2. Most of these studies focused mainly on the level of expression of BMP signaling proteins and
               the resultant cellular damage, describing only limited knowledge on molecular regulation and downstream
               targets. This article will focus mainly on the role of different BMP ligands and receptors on neuronal and
               glial cell differentiation, neuroinflammation, cell death, and autophagy in the in vivo and in vitro models
   54   55   56   57   58   59   60   61   62   63   64